Abstract: The object of the present invention is to provide a method for determining the sensitivity of a subject to an SGLT2 inhibitor, and a sensitivity marker for the SGLT2 inhibitor. The present invention provides a method for determining the sensitivity of a subject to an SGLT2 inhibitor, comprising measuring a biomarker in the biological sample of a subject, and determining the sensitivity of the subject to the SGLT2 inhibitor using the measured biomarker value as an indicator.
Type:
Application
Filed:
February 24, 2020
Publication date:
November 5, 2020
Applicants:
NIHON UNIVERSITY, OSAKI CITY, NIPPON KAYAKU KABUSHIKI KAISHA